ARCHIVES

The Clinical Trials Working Group: NCI panel considers plan to centralize clinical trial review and prioritization. NCI director faults system for duplication, “equivocal results.”

This article is from The Cancer Letter archive.

Vol. 30 No. 33 | August 13, 2004

Download PDF Visit The Full Archive

Related Articles

Study Finds Trial Results Reliable At Three Years

July 29, 2005

FDA Committee Okays Leuprolide NDA, But Recommends Against Mitoxantrne, Epirubicin

April 5, 1985

Carlson Named NCCN Chief Executive

September 28, 2012

NIH Cancer Nurse Turnover Down to 10%

July 24, 1987

ASCO Board Accepts Plan To Establish New Bethesda Headquarters, Hire Chief Officer

April 23, 1993

Artificial Neural Networks Predict Clinical Outcomes

November 26, 2004